10:00
World
·
Country
·
Local
·
Fun
Explained: Why India’s rejection of a TB drug patent matters for patients · Activ.news
Country
Listen
Save
⇱
Share
Delhi
31 Oct, 6:30 am IST
Explained: Why India’s rejection of a TB drug patent matters for patients
2m
What happened
Sources
Read at Indian Express ↗
Report an error